Novel Foods
Foods and ingredients without significant consumption history in the EU or other jurisdictions, requiring pre-market safety assessment and authorisation.
Foresight tracks Novel Foods developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.
Current activity
Intensifying
62% above the prior 8-week baseline
3-month trend
Latest alerts below
Last updated
5 April 2026, 18:51
Latest Novel Foods alerts
The most recent regulatory and guidance signals tracked by Foresight
EFSA Opens Consultation on Schizochytrium sp. (LU310) Oil Novel Food Application
EFSA has launched a public consultation on the safety of Schizochytrium sp. (LU310) oil as a novel food, closing April 6, 2026. A positive assessment will pave the way for market authorization, allowing food and supplement manufacturers to incorporate this specific microalgal oil into EU-compliant product formulations.
EU Commission Terminates Novel Food Authorisation Procedure for Magnesium Orotate Dihydrate
The European Commission has terminated the authorization procedure for magnesium orotate dihydrate, confirming it will not be added to the Union list of novel foods. Companies must ensure this substance is excluded from EU food supplement formulations to avoid market access restrictions and potential enforcement actions.
EFSA NDA Panel Finds 3′‑Sialyllactose (3′‑SL) Sodium Salt Produced with GM E. coli INB‑3SL_01 Safe as a Novel Food
EFSA has issued a positive safety opinion for 3′-sialyllactose (3′-SL) sodium salt produced via a new GM E. coli strain, confirming its safety as a novel food. This assessment clears a major regulatory hurdle for market entry, signaling an upcoming update to the EU Union list of novel foods and expanding production options for manufacturers.
EU PAFF Committee Publishes 14 April 2026 Agenda On Novel Foods And Recycled PET
The EU PAFF Committee is set to vote on new novel food authorizations, food additive specifications, and mechanical PET recycling processes on April 14, 2026. These decisions will expand market access for specific recycled plastics and novel ingredients, requiring food and packaging manufacturers to update compliance strategies for upcoming safety standards.
EFSA Registers Novel Food Application for Cell-Cultured Bovine Fat Biomass (Bos taurus)
EFSA has commenced the suitability check for a novel food application for cell-cultured bovine fat biomass, marking a formal step toward EU market access for cultivated meat components. This development signals the beginning of a multi-year risk assessment process that will set safety precedents for the alternative protein industry and future hybrid food products.
Louisiana SB 434 Would Treat Foods Containing Vaccines as Drugs
Louisiana SB 434 proposes reclassifying foods containing vaccines as "drugs" under state law, with potential implementation by August 2026. This shift would subject edible vaccine products to pharmaceutical-grade manufacturing and labeling standards, significantly increasing compliance complexity for biotechnology and novel food developers.
EU Commission Updates Union List of Novel Foods With New Authorisations and Akkermansia Labelling Changes
The EU has expanded its Union list of novel foods with new authorisations for rapeseed powder and lacto-N-tetraose, while tightening labelling and use conditions for pasteurised Akkermansia muciniphila. Manufacturers must align product formulations and marketing claims with these specific legal specifications to maintain market access and ensure compliance with updated probiotic safety standards.
EU EFSA NDA Panel Cannot Establish Safety of CO2 Hemp Extract Novel Food Under Regulation (EU) 2015/2283
EFSA has issued a negative scientific opinion on CO2 hemp extracts, concluding that safety cannot be established due to insufficient characterization and toxicological data. This decision reinforces the high evidentiary bar for cannabinoid-based novel foods, signaling continued market access delays and the need for more robust, substance-specific safety data.
Canada Approves Genetically Engineered PRRSV-Resistant Pigs For Food And Feed
Canada approved genetically engineered PRRSV-resistant pigs for food and feed use in January 2026. This alignment with major trading partners facilitates biotech adoption in the food supply chain and confirms that no special labeling is required for these gene-edited products.
EU Commission Terminates Novel Food Authorisation Procedure for Lithium Orotate Dihydrate (NF/2024/30250)
The European Commission has terminated the authorisation procedure for lithium orotate dihydrate as a novel food, effectively blocking its addition to the Union list. Companies should cease any plans for market entry of this substance in food or supplements, as it remains unauthorised for sale in the EU.
EU Commission Terminates Novel Food Authorisation Procedure for Epimedium sagittatum (NF 2021/2383) Without Union List Update
The European Commission has terminated the novel food authorization procedure for Epimedium sagittatum, refusing its addition to the Union list of authorized ingredients. Businesses must exclude this botanical from EU product formulations and market entry strategies to avoid non-compliance with novel food regulations.
European Commission Terminates Novel Food Procedure for Spilanthol Extract Powder (NF 2019/1394)
The European Commission has terminated the authorization procedure for Spilanthol extract powder as a novel food, effective March 2026. This confirms the ingredient remains unauthorized for the EU market, necessitating immediate formulation reviews and the suspension of market entry plans for affected food products.
European Commission Terminates Novel Food Procedure for Umi-Budo Without Union List Update
The European Commission has terminated the authorization procedure for Umi-budo (Caulerpa lentillifera) as a traditional food, effective March 2026. This decision maintains the ingredient's unauthorized status, requiring businesses to halt market entry plans or reformulate products to ensure compliance.
EU Commission Terminates Novel Food Authorisation Procedure for Ferrous Orotate Trihydrate (NF/2024/30113)
The European Commission has terminated the novel food authorisation procedure for ferrous orotate trihydrate, effectively blocking its addition to the Union list of approved substances. Companies should halt any market entry plans for this substance in the EU and review alternative iron sources for food and supplement applications.
EU Commission Terminates Novel Food Authorisation Procedure for Synthetic Cannabidiol (NF 2019/0935)
The European Commission has formally terminated the authorization procedure for synthetic cannabidiol as a novel food, effective March 2026. This decision reinforces the ongoing regulatory barrier for CBD products in the EU market, necessitating immediate reassessment of market access strategies and product pipelines for cannabinoid-based ingredients.
Germany BVL Publishes 2nd Edition of List of Algae and English Preface to Lists of Substances
Germany’s BVL has released the 2nd edition of the "List of Algae," updating the official classification framework for algae used in food and dietary supplements. Businesses must verify that algae-based ingredients align with these updated safety and regulatory profiles to mitigate risks related to unauthorized novel foods or medicinal product classifications.
EFSA Webinar on Risk Assessment of Cannabidiol as a Novel Food
EFSA will detail its updated safety assessment framework for Cannabidiol (CBD) as a novel food in a webinar on April 21, 2026. This guidance clarifies the scientific evidence required for novel food applications, directly impacting market access and compliance strategies for CBD-based products.
Austria Recalls Brownies From Czechia Over High Delta-9-THC and Unauthorised CBD (RASFF 2026.2498)
Austria has issued a serious risk notification and consumer recall for brownies containing excessive Delta-9-THC and unauthorized CBD. This enforcement action underscores the strict EU-wide scrutiny of cannabinoid-infused food products and the ongoing classification of CBD as an unauthorized novel food ingredient.
EU/EFSA Ongoing Risk Assessment on Modification of Authorised 2’-Fucosyllactose (2’-FL) Novel Food
EFSA is reviewing a modification to the authorized novel food 2’-Fucosyllactose (2’-FL), with a risk assessment deadline scheduled for April 2027. Operators should anticipate potential changes to technical specifications or permitted uses, though current market access remains unaffected during the ongoing scientific review.
Minnesota SF 4561 Agriculture Omnibus Would Update Compost, Plant Biostimulant, Cell-Cultured Food and Veterinary Drug Rules
Minnesota is advancing an omnibus bill (SF 4561) to update regulatory definitions for plant biostimulants, fertilizers, and cell-cultured food labeling by mid-2026. Impacted businesses must prepare for new labeling mandates for novel foods and stricter permitting and record-keeping requirements for agricultural inputs and veterinary pharmaceuticals.
Related topics
Not a newsletter. Not a feed.
Structured intelligence mapped to your business.
These are just a few of the most recent Novel Foods alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.
Book a demoFrequently asked questions
Everything you need to know about Foresight's regulatory intelligence platform
Still have questions? Get in touch with our team
Join 3,500+ professionals staying ahead
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at